Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-08-Speech-3-178"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-09-08"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20100908.10.3-178"2
lpv:hasSubsequent	lp_eu:2010-09-08-Speech-3-1792
lpv:speaker	lp:Françoise Grossetête2
lpv:spokenAs	member; EPP (2009-07-14--2014-06-30)3 substitute; Delegation for relations with Australia and New Zealand (2009-09-16--2014-06-30)3 member; ENVI (2009-07-16--2012-01-18)3 substitute; ITRE (2009-07-16--2012-01-18)3 member; Delegation for relations with the countries of Central America (2009-09-16--2014-06-30)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3 unknown; Union pour un Mouvement Populaire (2009-07-14--2014-06-30)3
lpv:translated text	"I supported this agreement for a second reading because we must respond to the reality of biomedical research and to patients’ needs while, at the same time, improving animal welfare. Fortunately, the number of animal experiments has fallen significantly over the last few years because European research is moving towards the aim of finding alternative solutions. Unfortunately, we know that these solutions are not available in certain cases, and so we have to resort to animal experimentation, in particular, on non-human primates. This is the case, for example, with all the neurodegenerative diseases, such as Parkinson’s disease and Alzheimer’s disease. Ensuring this research is conducted in Europe is our only guarantee of a high level of animal welfare protection. Concern for an animal’s pain during an experiment ensures that good results will be obtained. This is why we must prevent any relocation of animal experimentation outside Europe."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph